Chrissy Teigen Joins Sanofi Campaign for Early Diabetes Testing

Stock.adobe.com

Chrissy Teigin is the new face of Sanofi’s diabetes campaign.¹ The educational campaign is called Screen for Type 1, and it is focused on providing information about the importance of screening for the disease. According to Sanofi, blood tests can identify the condition before symptoms have begun to present themselves.

Teigen joined the campaign after her son Miles was diagnosed with the disease at just 6 years old. According to her, Miles briefly ended up in the hospital, and she hopes that by sharing her experiences as a mother that she can help other families avoid this.

In a press release, Teigen said, “Our family knew nothing about type 1 diabetes prior to 2024–and when I say nothing, I mean absolutely nothing. We were confused and scared when Miles was first diagnosed. Miles is a warrior–a type 1 diabetes warrior–and we are learning together every day how to help him manage this disease, but there is no doubt in my mind that knowing in advance would have made a positive impact for Miles, me, and our entire family. I want everyone to hear me when I say: stay proactive and talk to your doctor about getting yourself or your loved ones screened for type 1 diabetes today!"

In the same press release, Nadia Fontaine, head of US autoimmune type 1 diabetes franchise for Sanofi, added, “It's unacceptable that many people are still finding out about a type 1 diabetes diagnosis only when serious complications arise. We're energized to partner with Chrissy Teigen on the Screen For Type 1 movement and believe her story will strongly resonate with families and underscore the importance of early risk detection."

This is Sanofi’s latest endeavor to improve patient conditions. In October of last year, the company announced that it would be contributing $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine as part of the company’s goal of improving diversity in clinical trials.²

In a press release issued at the time, Sanofi’s senior vice president and global head of clinical trials and operations Lionel Bascles said, “At Sanofi, our mission is to chase the miracles of science to improve people's lives, and this means all people's lives, regardless of their race or ethnicity. By partnering with these three esteemed Historically Black College and University medical schools, we hope to facilitate new inroads to communities that have been underrepresented in healthcare for far too long. Increasing diversity and inclusion is essential to the research and development of medicines and vaccines for people of all backgrounds."

Valerie Montgomery Rice, MD, FACOG, president and CEO of the Morehouse School of Medicine added, “Morehouse School of Medicine is exceptionally grateful to Sanofi for this investment in our clinical study diversity Center of Excellence. We look forward to a robust partnership as we work to increase diversity in clinical studies and develop advanced opportunities for researchers, leading to greater health equity. More diversity in clinical studies will ensure traditionally underserved populations receive the very latest cutting-edge therapeutic innovations."

Sources

1. Chrissy Teigen - Author, Entrepreneur, Mom to Young Son with Type 1 Diabetes - Joins Sanofi's Screen For Type 1 Movement. Sanofi. April 15, 2025. https://www.prnewswire.com/news-releases/chrissy-teigen--author-entrepreneur-mom-to-young-son-with-type-1-diabetes--joins-sanofis-screen-for-type-1-movement-302426703.html
2. Sanofi Commits $18 million to Howard University College of Medicine, Meharry Medical College, and Morehouse School of Medicine to Increase Diversity in Clinical Studies. Sanofi. October 16, 2024. Accessed April 18, 2025. https://www.prnewswire.com/news-releases/sanofi-commits-18-million-to-howard-university-college-of-medicine-meharry-medical-college-and-morehouse-school-of-medicine-to-increase-diversity-in-clinical-studies-302276979.html